scholarly journals Depression and Treatment with Effective Herbs

2019 ◽  
Vol 25 (6) ◽  
pp. 738-745 ◽  
Author(s):  
Zohre Fathinezhad ◽  
Robert D.E Sewell ◽  
Zahra Lorigooini ◽  
Mahmoud Rafieian-Kopaei

Depression is a common psychiatric disease and one of the main causes of disability worldwide. In spite of certain developments in this field, chemical and synthetic drugs used for the treatment of depression disrupt the treatment process due to numerous side effects and high cost. Today, the goal of using a potential method for treating depression involves the use of medicinal and phytochemical plants, which have many therapeutic benefits. Studies have shown that medicinal plants affect the nervous system and exert antidepressant effects in various ways, including synaptic regulation of serotonin, noradrenaline and dopamine, and inflammatory mediators. In this study, depression as well as the factors and mechanisms involved in its development are first addressed, and then medicinal plants effective in the treatment of depression along with their mechanisms of actions are reported.

2017 ◽  
Vol 12 (1) ◽  
pp. 1 ◽  
Author(s):  
Zahra Rabiei ◽  
Sana Rabiei

<p class="Abstract">Depression is a life-threatening, debilitating, and common disease affecting different segments of community. Chemical and synthetic drugs available to treat this disease cause many adverse effects and may lead to complete recovery in only 50% of patients. At the same time, medicinal plants have been reported to exert optimal pharmacological effects in treating depression in different models. In this review, the relevant articles indexed in the reliable databases PubMed, PubMed central, Scopus and Web of Science were review-ed. The review indicated that most medicinal plants exerted antidepressant effects through synaptic regulation of serotonin, noradrenaline, and dopamine, regulating activity of hypothalamic-pituitary-adrenal axis, reinfor-cing anti-oxidant defense system, and decreasing inflammatory mediators. The medicinal plants and their active compounds can relieve depression through different pathways and hence are considered a new source to produce antidepressants.</p>


2019 ◽  
Vol 18 (2) ◽  
pp. 92-102 ◽  
Author(s):  
Fatma Tuğçe Gürağaç Dereli ◽  
Mert Ilhan ◽  
Esra Küpeli Akkol

Background & Objective: Depression, a risk factor for several serious diseases, is a highly prevalent and life-threatening psychiatric disorder. It can affect the individual’s position in life and reduce the living standards. The research on the use of medicinal plants in treating this disease has increased enormously because of the possible low rehabilitation rate and side effects of available synthetic drugs, such as sexual dysfunction, nausea, fatigue, insomnia, hypersomnia, and weight gain.Conclusion:Therefore, this review aimed to draw attention to the antidepressant effects of culinary herbs and traditional medicinal plants and their active components, thereby promoting their use in the development of more potent antidepressants with improved side effect profile.


Author(s):  
О. В. Савельєва ◽  
І. М. Владимирова

<p><strong>THE ANALYSIS OF NOMENCLATURE OF SEDATIVE AND somnolent DRUGS IN UKRAINE</strong></p><p><strong>Е.V. Savelyeva, I.N. Vladymyrova</strong></p><p>National University of Pharmacy, Kharkiv</p><pre><strong>Summary: </strong>the assortment of the modern sedative and somnolent drugs presented at the pharmaceutical market of Ukraine has been analyzed. It has been established that pharmaceutical manufactories of Ukraine occupy 76,70 % of market. Synthetic drugs occupy 22,33 % of market, plants drugs – 77,67 %. Monodrugs are presented by drugs of <em>Valeriana officinalis</em>, <em>Paeonia anomala</em> and <em>Leonurus cardiaca</em>. Results in relation to correlation of producing forms prove, that medicinal forms as pills and tincture occupy the largest segments. It established the monotony of species of medicinal plants, which is part of sedative and somnolent drugs.</pre><p><strong>Key words: </strong>sedative drugs, somnolent drugs, drugs nomenclature, phytotherapeutic drugs.</p><p><strong>Introduction. </strong>Nervous system diseases can result from a variety of reasons, including stress, violations of the day, inactive lifestyle, prolonged tension etc. Most of the adult population of the planet is experiencing problems with the nervous system. The most common way of life associated with a variety of stressors, and being the main reason of the most nervous disorders. Diseases of the nervous system can take many forms – from headaches to epileptic seizures. But completely eliminate stress from your life virtually impossible. The maximum that we can do is to reduce their number to a minimum. Drugs having a widespread action on neurotransmitters system with complex effect on the etiological factors, pathogenic link and symptomatic manifestations of the disease are used for this purpose.</p><p><strong>Research methods. </strong>This research was conducted by conventional statistical and marketing study of electronic and paper sources. The object of the work was information on sedatives and sleeping pills registered in Ukraine.</p><p><strong>Results and discussion</strong>. In order to study herbal sedatives and sleeping pills, registered in Ukraine, and analysis of medicinal plants species that are part of these medications, the nomenclature of this group of drugs on regional market was examined. According to the ATC classification system, drugs of this segment are represented by following groups: combined drugs of barbiturates; medications that close to benzodiazepines; Melatonin receptor agonists, bromides and dexmedetomidine drugs as well as a group of other sedatives and sleeping pills. The latter group includes drugs based on <em>Valeriana officinalis</em>, <em>Paeonia anomala</em> and <em>Leonurus cardiaca</em> and combined herbal preparations.</p><p>Analyzing the contribution of each country of origin provided on the domestic pharmaceutical market, it was found that sedatives and hypnotics of Ukrainian pharmaceutical companies occupies 76,70%; Germany - 6,80%; Poland – 2,91%; US, Czech Republic, Slovenia and France – 1,94%; Latvia, Turkey, Canada, Hungary, Finland, Belarus - 0,97%.</p><p>Analyzing the state of the Ukrainian pharmaceutical market of sedatives and sleeping pills origin was found that synthetic drugs occupy 22,33% of the market and herbal products – 77,67%.</p><p>Herbal medicines are divided into two groups: mono-drugs and combination herbal product. Mono-drugs are presented by <em>Valeriana</em>, <em>Paeonia </em>and <em>Leonurus </em>drugs. It should be noted the uniformity of dosage forms for this group.</p><p>When using phytotherapeutic remedies for effective therapy it is important take into account the mechanism of their action and specifics of pharmacological action on human’ body.</p><p><strong>Conclusions. </strong>Analyzing the types of medicinal plants that are present in sedatives and hypnotics, their monotony was established. The perspective in this area can be research of other types of medicinal plants having neurotransmitter action as a source for creating phytotherapeutic agents.</p>


Author(s):  
Abeer Fauzi Al-Rubaye ◽  
Mohanad Jawad Kadhim ◽  
Imad Hadi Hameed

The pharmacological mechanisms of the medicinal plants traditionally used for RA in Persian medicine are discussed in the current review. Further investigations are mandatory to focus on bioefficacy of these phytochemicals for finding novel natural drugs. Rheumatoid arthritis is chronic, progressive, disabling autoimmune disease characterized by systemic inflammation of joints, damaging cartilage and bone around the joints. It is a systemic disease which means that it can affect the whole body and internal organs such as lungs, heart and eyes. Although numbers of synthetic drugs are being used as standard treatment for rheumatoid arthritis but they have adverse effect that can compromise the therapeutic treatment. Unfortunately, there is still no effective known medicinal treatment that cures rheumatoid arthritis as the modern medicine can only treat the symptoms of this disease that means to relieve pain and inflammation of joints. It is possible to use the herbs and plants in various forms in order to relieve the pain and inflammation in the joints. There are so many medicinal plants that have shown anti rheumatoid arthritis properties. So the plants and plant product with significant advantages are used for the treatment of rheumatoid arthritis. The present review is focused on the medicinal plants having anti rheumatoid arthritis activity


2019 ◽  
Vol 20 (5) ◽  
pp. 354-365 ◽  
Author(s):  
Víctor M. Muñoz-Pérez ◽  
Mario I. Ortiz ◽  
Raquel Cariño-Cortés ◽  
Eduardo Fernández-Martínez ◽  
Leticia Rocha-Zavaleta ◽  
...  

Background:Worldwide, the progress in reducing neonatal mortality has been very slow. The rate of preterm birth has increased over the last 20 years in low-income and middle-income countries. Its association with increased mortality and morbidity is based on experimental studies and neonatal outcomes from countries with socioeconomic differences, which have considered implementing alternative healthcare strategies to prevent and reduce preterm births.Methods:Currently, there is no widely effective strategy to prevent preterm birth. Pharmacological therapies are directed at inhibiting myometrial contractions to prolong parturition. Some drugs, medicinal plants and microorganisms possess myorelaxant, anti-inflammatory and immunomodulatory properties that have proved useful in preventing preterm birth associated with inflammation and infection.Results:This review focuses on the existing literature regarding the use of different drugs, medicinal plants, and microorganisms that show promising benefits for the prevention of preterm birth associated with inflammation and infection. New alternative strategies involving the use of PDE-4 inhibitors, medicinal plants and probiotics could have a great impact on improving prenatal and neonatal outcomes and give babies the best start in life, ensuring lifelong health benefits.Conclusion:Despite promising results from well-documented cases, only a small number of these alternative strategies have been studied in clinical trials. The development of new drugs and the use of medicinal plants and probiotics for the treatment and/or prevention of preterm birth is an area of growing interest due to their potential therapeutic benefits in the field of gynecology and obstetrics.


Plants ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 838
Author(s):  
Laura Grațiela Vicaș ◽  
Mariana Eugenia Mureșan

The therapeutic benefits of medicinal plants are well known and have been collected as important data on ethnomedicine [...]


2019 ◽  
Vol 21 (1) ◽  
pp. 163 ◽  
Author(s):  
Pit Shan Chong ◽  
Man-Lung Fung ◽  
Kah Hui Wong ◽  
Lee Wei Lim

Depression is a common and severe neuropsychiatric disorder that is one of the leading causes of global disease burden. Although various anti-depressants are currently available, their efficacies are barely adequate and many have side effects. Hericium erinaceus, also known as Lion’s mane mushroom, has been shown to have various health benefits, including antioxidative, antidiabetic, anticancer, anti-inflammatory, antimicrobial, antihyperglycemic, and hypolipidemic effects. It has been used to treat cognitive impairment, Parkinson’s disease, and Alzheimer’s disease. Bioactive compounds extracted from the mycelia and fruiting bodies of H. erinaceus have been found to promote the expression of neurotrophic factors that are associated with cell proliferation such as nerve growth factors. Although antidepressant effects of H. erinaceus have not been validated and compared to the conventional antidepressants, based on the neurotrophic and neurogenic pathophysiology of depression, H. erinaceus may be a potential alternative medicine for the treatment of depression. This article critically reviews the current literature on the potential benefits of H. erinaceus as a treatment for depressive disorder as well as its mechanisms underlying the antidepressant-like activities.


Molecules ◽  
2021 ◽  
Vol 26 (4) ◽  
pp. 778
Author(s):  
James N. Campbell ◽  
Randall Stevens ◽  
Peter Hanson ◽  
James Connolly ◽  
Diana S. Meske ◽  
...  

Capsaicin is a potent agonist of the TRPV1 channel, a transduction channel that is highly expressed in nociceptive fibers (pain fibers) throughout the peripheral nervous system. Given the importance of TRPV1 as one of several transduction channels in nociceptive fibers, much research has been focused on the potential therapeutic benefits of using TRPV1 antagonists for the management of pain. However, an antagonist has two limitations. First, an antagonist in principle generally only affects one receptor. Secondly, most antagonists must have an ongoing presence on the receptor to have an effect. Capsaicin overcomes both liabilities by disrupting peripheral terminals of nociceptive fibers that express TRPV1, and thereby affects all of the potential means of activating that pain fiber (not just TRPV1 function). This disruptive effect is dependent on the dose and can occur within minutes. Thus, unlike a typical receptor antagonist, continued bioavailability at the level of the receptor is not necessary. By disrupting the entire terminal of the TRPV1-expressing nociceptive fiber, capsaicin blocks all the activation mechanisms within that fiber, and not just TRPV1 function. Topical capsaicin, an FDA approved treatment for neuropathic pain, addresses pain from abnormal nociceptor activity in the superficial layers of the skin. Effects after a single administration are evident over a period of weeks to months, but in time are fully reversible. This review focuses on the rationale for using capsaicin by injection for painful conditions such as osteoarthritis (OA) and provides an update on studies completed to date.


1978 ◽  
Vol 6 (6) ◽  
pp. 421-429 ◽  
Author(s):  
A Delini-Stula ◽  
E Radeke ◽  
A Vassout

Three different aspects of the psychopharmacological activity of the antidepressant maprotiline were investigated: its influence on serotoninergic functions the effects produced by chronic treatment its central nervous depressant and anxiolytic properties. Study of the effects of maprotiline on 5-HTP-induced head-twitch in mice pre-treated with pargyline or on hyperpyrexia in rats provided no evidence that the drug interferes with serotonin-mediated functions in the central nervous system even after quite high doses. These findings corroborate the results of extensive neurobiochemical investigations, which failed to demonstrate any influence of maprotiline on the metabolism of serotonin. Chronic studies showed that classical effects of maprotiline such as antagonism against reserpine-induced ptosis or tetrabenazine-induced catalepsy do not change in their intensity after daily administration of the drugs in a dose of 30 mg/kg p.o.for 11 days. A new component of the action of the compound, not detectable after one single dose, seems to appear, however, after repeated treatment (8 days). This effect is manifested in the restoration of conditioned avoidance behaviour after its suppression by pre-treatment with reserpine. The same effect is produced by imipramine. It is suggested that this restorative effect may be due to an additional activation of the dopaminergic nervous system and may have a bearing on the appearance of clinical antidepressant effects. Maprotiline was found to potentiate central nervous depressant effects of drugs like chlorpromazine, phenobarbitone and propranolol. This affords further confirmation that, in addition to its antidepressant qualities, it possesses sedative actions. An anxiolytic component was also demonstrated in rats in which maprotiline suppressed the conditioned, fear-induced rise in body-temperature.


Sign in / Sign up

Export Citation Format

Share Document